Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
|Articles|October 28, 2022
- October 2022
- Volume 88
- Issue 10
October Pet Peeves
Advertisement
Missed Call
When the pharmacy calls a patient and leaves a voicemail message about a prescription, and the patient calls back and says they did not listen to the message and asks what the call was about.
Getting Carded
Patients who show up to get COVID-19 boosters and leave their CDC cards at home. They get reminders to have the cards but still say, “Oh, I didn’t know I’d need to bring that.”
Positively Dreadful
Patients who test positive for COVID-19 and then arrive without a mask on to pick up their Rx.
Articles in this issue
almost 4 years ago
October Fun Factsalmost 4 years ago
Investigators Suggest Conjunctivitis May Transmit Monkeypoxalmost 4 years ago
Women Pharmacist Day Focuses on Achievements in the Professionalmost 4 years ago
October Generic Product Newsalmost 4 years ago
Pharmacists Play Pivotal Role in Increasing Awareness of Prediabetesalmost 4 years ago
October Generic Focusalmost 4 years ago
Federal ECHO Act Helps Goal of Health Equityalmost 4 years ago
October Rx Product NewsAdvertisement
Related to this article
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.
Pharmacists play a key role in guiding age- and risk-based vaccination decisions to protect against invasive and noninvasive disease.
Peer Reviewed
Gepotidacin and zoliflodacin show comparable efficacy to standard care for urogenital gonorrhea, offering promising alternatives given the recent rise in antimicrobial resistance.
With nearly 8 in 10 older adults misusing at least 1 OTC product, clearer counseling and labels could close the gap.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
2
FDA Approves Levacetylleucine to Treat Ataxia in Adult, Pediatric Patients With A-T
3
Adult Respiratory Vaccination Delivers Up to $12 in Societal Value for Every $1 Spent, Analysis Finds
4
Baseline Interferon Activity in Monocytes Predicts mRNA Vaccine Adverse Effects, Study Finds
5